Profil
Stephen Hitchcock is currently a Director at both the Structural Genomics Consortium and Cerevance, Inc. Previously, he worked as an Executive Director-Medicinal Chemistry at Amgen, Inc., a Principal at Eli Lilly & Co., and a Senior Vice President-Drug Discovery at Envoy Therapeutics, Inc. He holds a doctorate degree from The University of Nottingham.
Postes actifs de Stephen Hitchcock
| Sociétés | Poste | Début |
|---|---|---|
Structural Genomics Consortium
Structural Genomics Consortium Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that determines three-dimensional structures of proteins of medical relevance | Directeur/Membre du Conseil | - |
Cerevance, Inc.
Cerevance, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Directeur/Membre du Conseil | - |
Anciens postes connus de Stephen Hitchcock
| Sociétés | Poste | Fin |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Envoy Therapeutics, Inc.
Envoy Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for treatment of neurological and psychiatric diseases | Corporate Officer/Principal | - |
Formation de Stephen Hitchcock
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
The University of Nottingham
The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Envoy Therapeutics, Inc.
Envoy Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for treatment of neurological and psychiatric diseases | Health Technology |
Structural Genomics Consortium
Structural Genomics Consortium Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that determines three-dimensional structures of proteins of medical relevance | Commercial Services |
Cerevance, Inc.
Cerevance, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Health Technology |
















